Ignite Creation Date:
2024-05-06 @ 6:20 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05625087
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2022-11-14
Brief Title:
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive HR Non-HER2 Expressing HER2- Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-14
First Submit QC Date:
November 14 2022
Study First Post Date:
2022-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-20
Last Update Post Date:
2024-06-24
Last Update Post Date Type:
ACTUAL